Gene 16 Whitening Factor

Manufacturer: Shanghai Liangliang Bio Technology Co., Ltd
Effective date: 2026-01-23
Label type: HUMAN OTC DRUG LABEL
Version: 33037
Source: full-release
Hydrated at: 2026-06-01 01:34:40

Label at a glance#

ProductGene 16 Whitening Factor

Active ingredientALLANTOIN

Label structure11 sections

Storage and handling

Keep in a dry, cool place away from direct sunlight. Store at room temperature.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Allantoin 0.5%

Purpose

OTC - PURPOSE SECTION

Allantoin Skin Lightener

Skin Protectant

Warning

WARNINGS SECTION

For External Use Only.

Use

INDICATIONS & USAGE SECTION

Apply moderate amount of the product on the skin.

Stop Using the Product if

OTC - STOP USE SECTION

Stop using the product when you have skin problems or the product disagrees with your skin.
・Stop using the product immediately and consult a dermatologist if you have redness, swelling, itching or irritation on the skin while or after using the product.
・If the product gets into the eyes, don't rub but rinse with water.

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

When Using the Product

DOSAGE & ADMINISTRATION SECTION

Mix one tablet with water in palm to dissolve before applying to skin. Two tablets two times a day. One after face cleanse in the morning; and one before bed.

Other Information

STORAGE AND HANDLING SECTION

Keep in a dry, cool place away from direct sunlight. Store at room temperature.

Contact the Manufacturer or Distributor

SPL UNCLASSIFIED SECTION

Manufactured by Shanghai Liangliang Bio Technology Co., Ltd
No. 876, TaoGan Road, Sheshan Town, Songjiang District, Shanghai 201602, China
(86)21-57794082

Distributed by Shanghai Liangliang Bio Technology Co., Ltd (USA)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

HYALURONIC ACID, TREHALOSE, MANNITOL, GLYCYRRHIZA GLABRA, CENTELLA ASIATICA, RESVERATROL, ARBUTIN, NIACINAMIDE, LECITHIN SOYBEAN, CERAMIDE 3, TOCOPHEROL, ASTAXANTHIN, PUNICA GRANATUM WHOLE

Drug Facts

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

product description

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69764-001-10	2026-01-23	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2025-07-29	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2024-12-18	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2024-07-30	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2024-01-30	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2023-12-29	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2023-07-28	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2022-12-22	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2022-07-29	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2021-12-17	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd
69764-001-10	2021-07-23	C162847	48780-1	c7ccaba7-20a3-fd44-e053-dadaa90aa01b	Shanghai Liangliang Bio Technology Co., Ltd

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
69764-001-10	Gene 16 Whitening Factor	1 in 1 PACKAGE	TABLET, SOLUBLE	1		33037
69764-001-10	Gene 16 Whitening Factor	7 mg in 1 POUCH	TABLET, SOLUBLE	7		33037

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALLANTOIN	ACTIVE INGREDIENT	344S277G0Z	3133
ALLANTOIN	ACTIVE MOIETY	344S277G0Z	3133
ARBUTIN	INACTIVE INGREDIENT	C5INA23HXF	3133
ASTAXANTHIN	INACTIVE INGREDIENT	8XPW32PR7I	3133
CENTELLA ASIATICA	INACTIVE INGREDIENT	7M867G6T1U	3133
CERAMIDE 3	INACTIVE INGREDIENT	4370DF050B	3133
GLYCYRRHIZA GLABRA	INACTIVE INGREDIENT	2788Z9758H	3133
HYALURONIC ACID	INACTIVE INGREDIENT	S270N0TRQY	3133
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	3133
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	3133
NIACINAMIDE	INACTIVE INGREDIENT	25X51I8RD4	3133
PUNICA GRANATUM WHOLE	INACTIVE INGREDIENT	O2ZTS50U5E	3133
RESVERATROL	INACTIVE INGREDIENT	Q369O8926L	3133
TOCOPHEROL	INACTIVE INGREDIENT	R0ZB2556P8	3133
TREHALOSE	INACTIVE INGREDIENT	B8WCK70T7I	3133

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

Gene 16 Whitening Factor
Allantoin
HYALURONIC ACID
TREHALOSE
MANNITOL
GLYCYRRHIZA GLABRA
CENTELLA ASIATICA
RESVERATROL
ARBUTIN
NIACINAMIDE
LECITHIN, SOYBEAN
CERAMIDE 3
TOCOPHEROL
ASTAXANTHIN
PUNICA GRANATUM WHOLE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
69764-001	69764-001-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ALLANTOIN	344S277G0Z	ACTIB
HYALURONIC ACID	S270N0TRQY	IACT
TREHALOSE	B8WCK70T7I	IACT
MANNITOL	3OWL53L36A	IACT
GLYCYRRHIZA GLABRA	2788Z9758H	IACT
CENTELLA ASIATICA	7M867G6T1U	IACT
RESVERATROL	Q369O8926L	IACT
ARBUTIN	C5INA23HXF	IACT
NIACINAMIDE	25X51I8RD4	IACT
LECITHIN, SOYBEAN	1DI56QDM62	IACT
CERAMIDE 3	4370DF050B	IACT
TOCOPHEROL	R0ZB2556P8	IACT
ASTAXANTHIN	8XPW32PR7I	IACT
PUNICA GRANATUM WHOLE	O2ZTS50U5E	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 81 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
MANNITOL	MANNITOL	3OWL53L36A	GRANULE / ORAL		1328 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER / RESPIRATORY (INHALATION)		6 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS		180 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
NIACINAMIDE	NIACINAMIDE	25X51I8RD4	CREAM / TOPICAL	NA		Exact identifier — unii candidate 4 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, COATED / ORAL	177.7 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS		181 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER / ORAL		4352 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		1568 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER, FOR SUSPENSION / INTRAMUSCULAR	6.75 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	GUM, CHEWING / BUCCAL		891 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	980.4 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / OPHTHALMIC	4.7 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER, FOR SUSPENSION / ORAL		7093 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TROCHE / ORAL		14594 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION/ DROPS / TOPICAL	0.3 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE / ORAL		1562 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, CHEWABLE / ORAL		3726 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE, EXTENDED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET / ORAL		3391 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	GRANULE, FOR SUSPENSION / ORAL		6000 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SOLUTION / INTRAVENOUS		15400 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CONCENTRATE / INTRAVENOUS		220 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / SUBCUTANEOUS	4.54 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SOLUTION / SUBCUTANEOUS		99 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
TOCOPHEROL	TOCOPHEROL	R0ZB2556P8	TABLET / ORAL	0.08 mg		Exact identifier — unii candidate 5 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SOLUTION / PARENTERAL	200 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, EXTENDED RELEASE / ORAL		1086 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION / SUBCUTANEOUS		675 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
TOCOPHEROL	TOCOPHEROL	R0ZB2556P8	CREAM / TOPICAL	NA		Exact identifier — unii candidate 5 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	GEL / OPHTHALMIC		25 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION / OPHTHALMIC		9 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		658 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR		105 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
LECITHIN, SOYBEAN	SOYBEAN LECITHIN	1DI56QDM62	CREAM / VAGINAL	1 %w/w		Exact identifier — unii candidate 7 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SUSPENSION / INTRAMUSCULAR		71 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
LECITHIN, SOYBEAN	SOYBEAN LECITHIN	1DI56QDM62	AEROSOL, METERED / RESPIRATORY (INHALATION)	0.1 %w/w		Exact identifier — unii candidate 7 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION, GEL FORMING / DROPS / OPHTHALMIC		4 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SOLUTION / SUBMUCOSAL	2.94 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / SUBLINGUAL	10.25 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		616 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION/ DROPS / OPHTHALMIC	3.3 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
TOCOPHEROL	TOCOPHEROL	R0ZB2556P8	CAPSULE, COATED / ORAL	0.25 mg		Exact identifier — unii candidate 5 equally ranked IID candidates
TOCOPHEROL	TOCOPHEROL	R0ZB2556P8	INJECTION, EMULSION / INTRAVENOUS	0.02 %w/v		Exact identifier — unii candidate 5 equally ranked IID candidates
LECITHIN, SOYBEAN	SOYBEAN LECITHIN	1DI56QDM62	TABLET, FILM COATED / ORAL	0.33 mg		Exact identifier — unii candidate 7 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, DELAYED RELEASE / ORAL		639 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION, EXTENDED RELEASE / ORAL	2464.6 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	300 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE, COATED PELLETS / ORAL		14 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		113 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		15400 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		543 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION/ DROPS / OPHTHALMIC	4.6 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE, DELAYED RELEASE / ORAL		2043 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SUSPENSION / INTRAVENOUS	2.5 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SPRAY / NASAL	41.5 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / ORAL		869 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
LECITHIN, SOYBEAN	SOYBEAN LECITHIN	1DI56QDM62	POWDER, FOR SUSPENSION / ORAL		39 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / TOPICAL	4 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER, FOR SOLUTION / ORAL		3767 mg	Exact identifier — unii candidate 65 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
292b677d-cbe2-4962-9406-123e272e54ea			b0a99964-d906-4c1d-8256-8c18dd9f88a6	2026-01-23	Warnings	Exact identifier spl id: 292b677d-cbe2-4962-9406-123e272e54ea spl set id: b0a99964-d906-4c1d-8256-8c18dd9f88a6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.